Genovis Enters into Distribution Agreement with Spanish Teknokroma

Today Genovis signed a distribution agreement with Teknokroma for exclusive rights to sell and market Genovis products on the Spanish and Portuguese markets.

Genovis has developed unique technological aids for medical research. In September 2007 the products were ready to be marketed to customers. Since then Genovis has worked on introducing the products to customers and continues to expand its sales channels in Europe.

So far this year Genovis has signed agreements with distributors for the Korean, Swedish, Danish, British, and Irish markets. In the United States Genovis works through its subsidiary Genovis Inc.

Through the Spanish distribution agreement Genovis is now taking yet another important step in its expansion in the European market.

" Teknokroma is a key player in Spain and Portugal and this agreement is yet another step in our strategy to build a sales organization together with effective and experienced partners in their respective home markets. " Teknokroma has extensive practical experience in sales to laboratories as well as the well-established customer contacts we need now that we are introducing our products," says Sarah Fredriksson, CEO of Genovis.

Teknokroma is an international enterprise with 30 years of experience in chromatography and a product portfolio consisting of more than 40,000 products. With a team of highly qualified chemists, pharmacists, and technicians in an environment that encourages initiative, creativity, and enthusiasm, Teknokroma ensures satisfied customers.

"Our focus is to introduce the latest technologies and we are therefore extremely pleased to be able to work with Genovis, which has the latest and most advanced technology and completely unique products. The Spanish market for gene transfer techniques has experienced incredible growth in recent years and through this agreement we will become a part of this exciting trend," says Rafael Nadal, President of Teknokroma.

Genovis offers new technological solutions in transfection, RNAi, imaging, and antibody tools to customers who work with sophisticated research in pharmaceutical companies and within the academic research community. Its market strategy to provide customers with effective support and service is to choose partners with strong customer relations in different geographic markets in the product families in which Genovis is active.